LSD1 inhibitors trigger myeloid differentiation by targeting the LSD1-GSE1 interaction on chromatin
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2021-12-09
相关数据集
A DNA Hypomethylation Signature Predicts Novel Anti-Tumor Activity of LSD1 Inhibitors in SCLC (BeadChip)
Epigenetic dysregulation has emerged as an important mechanism in cancer. Alterations in epigenetic machinery have become a major focus for new targeted therapies. The current report describes the d
NIAID Data Ecosystem60
LSD1 inhibitors trigger myeloid differentiation by targeting the LSD1-GSE1 interaction on chromatin [ChIP-seq]. LSD1 inhibitors trigger myeloid differentiation by targeting the LSD1-GSE1 interaction on chromatin [ChIP-seq]
The histone de-methylase LSD1 is over-expressed in different haematological tumours, like AML, where it sustains carcinogenesis by promoting the clonogenic potential of leukemic stem cells. Emerging a
NIAID Data Ecosystem40
Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia [anti-H3K9 ac, anti-H3K27, RCOR1, SPI1, and MLL4 ChIP-Seq]. Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia [anti-H3K9 ac, anti-H3K27, RCOR1, SPI1, and MLL4 ChIP-Seq]
To determine whether changes in histone modifications directly correlate with changes in transcription, THP1 AML cells were treated with a potent and selective LSD1 inhibitor (OG86, 250nM) and then su
NIAID Data Ecosystem30
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001. Homo sapiens
The goal of this study was to understand how the LSD1 inhibitor RG6016/ORY1001 leads to selective efficacy in subsets of small cell lung cancer. SCLC cell lines, PDX models studied ex vivo and studied
NIAID Data Ecosystem50
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis [BcorKrasChIP-seq]. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis [BcorKrasChIP-seq]
Investigation of the transcriptional changes in BcorΔE9-10KrasG12D myeloid progenitors Overall design: BcorΔE9-10KrasG12D tumours were transplanted into PTPRCA recipients, after 4 weeks donor-derived
NIAID Data Ecosystem30
